BA
ARNA

BlackRock Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

BlackRock Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$358K Buy
25,205
+12,589
+100% +$195K ﹤0.01% 2408
2016
Q3 		$221K Buy
12,616
+672
+6% +$11.1K ﹤0.01% 2636
2016
Q2 		$204K Buy
11,944
+701
+6% +$12.5K ﹤0.01% 2600
2016
Q1 		$221K Buy
11,243
+803
+8% +$12.9K ﹤0.01% 2504
2015
Q4 		$198K Sell
10,440
-4,843
-32% -$98.8K ﹤0.01% 2580
2015
Q3 		$292K Sell
15,283
-5,664
-27% -$192K ﹤0.01% 2515
2015
Q2 		$972K Buy
20,947
+5,717
+38% +$248K ﹤0.01% 1685
2015
Q1 		$666K Buy
15,230
+3,083
+25% +$143K ﹤0.01% 1862
2014
Q4 		$422K Sell
12,147
-548
-4% -$22.2K ﹤0.01% 2114
2014
Q3 		$532K Sell
12,695
-225
-2% -$10K ﹤0.01% 1918
2014
Q2 		$757K Sell
12,920
-98,196
-88% -$6.18M ﹤0.01% 1697
2014
Q1 		$7M Buy
111,116
+6,965
+7% +$462K 0.01% 899
2013
Q4 		$6.09M Buy
104,151
+88,775
+577% +$4.64M 0.01% 944
2013
Q3 		$810K Buy
15,376
+2,311
+18% +$155K ﹤0.01% 1553
2013
Q2 		$1.01M Buy
+13,065
New +$1.07M ﹤0.01% 1378

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BlackRock Advisors's ARNA Position: Q4 2016 in Review

BlackRock Advisors increased its Arena Pharmaceuticals Inc (ARNA) stake by 100% in Q4 2016, buying an estimated $195K and bringing the position to 25,205 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

BlackRock Advisors first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $7M in Q1 2014. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • BlackRock Advisors held 25,205 shares of Arena Pharmaceuticals Inc worth $358K as of Q4 2016.
  • BlackRock Advisors bought 12,589 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $195K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2408 holding.
  • BlackRock Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Arena Pharmaceuticals Inc position peaked at $7M in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.